Natural killer cell activity in Hodgkin's disease patients undergoing radiation therapy or chemotherapy and radiation therapy

Clinical and Laboratory Haematology

Volumn 20, Issue 5, 1998, Pages 303-306

  Pinel, M Izabel Sathler ^a,c   Esteves, Eliane Barbosa ^a   Rumjanek, Vivian M ^b  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c NONE   (Brazil)

Author keywords

Chemotherapy; Hodgkin's disease; Natural killer cell activity; Radiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CYTOTOXICITY; DRUG RESPONSE; HODGKIN DISEASE; HUMAN; NATURAL KILLER CELL; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; HODGKIN DISEASE; HUMANS; KILLER CELLS, NATURAL; MIDDLE AGED; RADIOTHERAPY; TREATMENT OUTCOME;

EID: 0031785170     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.1998.00150.x     Document Type: Article

References (16)

1. Al Sam S., Jones D.B., Payne S.V. & Wright D.H. (1982) Natural killer (NK) activity in the spleen of patients with Hodgkin's disease and controls. British Journal of Cancer 46, 806-810.
2. Brovall C. & Schacter B. (1981). Radiation sensitivity of human natural killer cell activity: control by X-linked genes. Journal of Immunology 126, 2236-2239.
3. Dean D.M., Pross H.F. & Kennedy J.C. (1978). Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells-III. International Journal of Radiation Oncology Biology Physics 4, 633-641.
4. Frydecka I. (1985). Natural killer cell activity during the course of disease in patients with Hodgkin's disease. Cancer 56, 2799-2803.
5. Gupta S. & Fernandes G. (1982). Natural killing in patients with Hodgkin's disease. In: Herberman RB, ed. NK Cells and Other Natural Effector Cells. Academic Press: New York: 1201-1206.
6. Hoppe R.T. (1998) Hodgkin's disease: In: Perez C.A., Brady L.W. eds. Principles and Practice of Radiation Oncology. Lippincott-Raven Publishers, Philadelphia: 1967
7. Levin J. (1987). Testes nao-parametricos. In: Levin J., ed. Estatistica Aplicada a Ciencias Humanas. Harper & Row do Brasil, São Paolo: 244-265.
8. Macklis R.M., Mauch P.M., Burakoff S.J. & Smith B.R. (1992). Lymphoid irradiation results in long-term increases in natural killer cells in patients treated for Hodgkin's disease. Cancer 69, 778-783.
9. Macklis R.M., Mauch P.M., Thompson L., Burakoff S.J. & Smith B.R. (1993). Phenotypic and functional analysis of expanded natural killer cell subpopulations in Hodgkin's disease patients treated with lymphoid irradiation. Oncology 50, 323-328.
10. Mauch P., Constine L., Greenberger J et al. (1995). Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. International Journal of Radiation Oncology Biology, Physics 31, 1319-1339.
11. Mizutani Y., Uchida A., Fujimoto T., Ikenaga M. & Yoshida O. (1989). Enhancement by X-ray irradiation of target cell susceptibility to natural killer cells. Immunology Letters 22, 247-252.
12. Onsrud M. & Thorsby E. (1981). Long-term changes in natural killer activity after external pelvic radiotherapy. International Journal of Radiation Oncology, Biology and Physics 7, 609-614.
13. Pinel M.I.S., Esteves E.B. & Rumjanek V.M. (1995). Increased natural killer activity in uterine cervix cancer patients undergoing radiation therapy. Natural Immunity 14, 216-224.
14. Rajaram N., Tatake R.J., Advani S.H. & Gangal S.G. (1990). Natural killer and lymphokine activated killer cell functions in Hodgkin's disease. British Journal of Cancer 62, 205-208.
15. Weiss L. & Slavin S. (1994). Effect of total lymphoid irradiation on natural killer cells and cytotoxic and primed T-lymphocytes. Israel Journal of Medical Sciences 30, 253-259.
16. Zarcone D., Tilden A.B., Lane V.G. & Grossi C.E. (1989). Radiation sensitivity of resting and activated nonspecific cytotoxic cells of T lineage and NK lineage. Blood 73, 1615-1621.